查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
溶瘤病毒免疫治疗市场，按产品类型、按应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1408906

溶瘤病毒免疫治疗市场，按产品类型、按应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Oncolytic Virus Immunotherapy Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年溶瘤病毒免疫治疗市场规模为1.1亿美元，2024年至2032年CAGR为24.5%。

溶瘤病毒免疫治疗市场-市场动态

加强合作推动市场需求

预计不断增加的合作将推动预测期内的市场成长。例如，2022 年 1 月，Siga Technologies 和 Bioarchitech 建立了临床前合作伙伴关係，研究免疫疗法作为癌症治疗方法。 TPOXX (tecovirimat) 和 Bioarchitech 的专利「基于痘苗的免疫疗法平台」是该研究合作伙伴关係的主题，该平台利用定制抗体和溶瘤病毒基因组中发现的其他蛋白质。此外，由于IT、网路和人工智慧技术的领导者NEC公司与生物技术公司Transgene签署了进一步开发合作协议，客製化新抗原癌症疫苗TG4050的临床评估将在2024年1月继续进行。设计和开发基于病毒的免疫疗法来治疗癌症。

溶瘤病毒免疫治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 24.5% 左右的CAGR成长
  • 根据应用细分，前列腺癌预计将在预计的时间内以显着的速度成长
  • 根据最终用户细分，医院细分市场预计将在预测期内主导市场
  • 从地区来看，预计北美在预测期内将占据显着的市场份额

溶瘤病毒免疫治疗市场-細項分析：

  • 全球溶瘤病毒免疫治疗市场根据产品类型、应用、最终用户和地区进行细分。
  • 根据产品类型，市场分为基于痘苗病毒的溶瘤病毒、基于水疱性口炎病毒的溶瘤病毒、以HSV为基础的溶瘤病毒、基于腺病毒的溶瘤病毒和基于新城疫病毒的溶瘤病毒。
  • 根据应用，全球产业分为前列腺癌、膀胱癌、黑色素瘤、卵巢癌、乳癌、肺癌、骨髓瘤等。预计前列腺癌在预计的时间内将以显着的速度成长。该领域的成长归因于前列腺癌盛行率的增加。例如，根据次要分析，除皮肤癌外，摄护腺癌是男性最常见的癌症。预计到 2023 年，美国将有 288,300 名男性被诊断出前列腺癌。2020 年，全球预计将有 1,414,259 人被诊断出前列腺癌。它是全球第四常见的癌症。
  • 根据最终用户，市场分为专科诊所、医院和癌症研究所。预计医院领域将在预测期内主导市场。在医院环境中，合格的医务人员可以在治疗期间和治疗后密切关注患者，通常会进行溶瘤病毒免疫治疗。医院也经常参与溶瘤病毒免疫治疗的临床研究。在许多癌症类型中，这些研究评估某些治疗的安全性和有效性。

溶瘤病毒免疫治疗市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美在预测期内将占据显着的市场份额，因为与其他国家相比，患者数量正在增长。由于美国癌症发生率的上升，该市场正在扩大。根据美国癌症协会的 2021 年报告，2021 年美国有 608,570 人死于癌症，同时预计将发现 190 万新癌症病例。促进市场成长的其他原因包括对不同癌症疗法的了解增加、该地区复杂的免疫肿瘤药物的可用性以及美国等国家不断扩大的医疗保健支出。美国医疗保险和医疗补助服务中心（CMS）发布的资料显示，2020年美国医疗保健支出成长9.7%，达到4.1兆美元，即每人12,530美元。医疗支出占该国GDP的19.7%。从而推动该地区的市场扩张。

溶瘤病毒免疫疗法市场-竞争格局：

市场上的主要参与者有： Amgen, Inc.、Sorrento Therapeutics Inc.、Merck & Co., Inc.、Oncolytics Biotech, Inc.、Viralytics Ltd.、上海三维生物科技有限公司、SillaJen, Inc.。 、RIGVIR Ltd.、ORYX GmbH & Co. KG、Cold Genesys, Inc. 和Transgene Biotek Ltd.。这些参与者采取了各种策略来维持市场竞争力，包括产品发布、收购、合作、协议等。

最近的发展：

2022 年 7 月，专注于基因和癌症疗法、候选疫苗和其他应用的病毒的创建和生产的纯粹合约开发和製造组织 (CDMO) ABL 宣布与私营生物技术企业 KaliVir 免疫治疗公司合作创建最先进的下一代溶瘤病毒免疫治疗计划。对于即将进行的临床研究，ABL 将生产 KaliVir 开发的溶瘤病毒。

目录

第一章：溶瘤病毒免疫治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的溶瘤病毒免疫疗法市场片段
    • 溶瘤病毒免疫疗法市场片段（依应用）
    • 最终用户的溶瘤病毒免疫治疗市场片段
    • 按国家/地区分類的溶瘤病毒免疫疗法市场片段
    • 按地区分類的溶瘤病毒免疫治疗市场片段
  • 竞争洞察

第 3 章：溶瘤病毒免疫疗法主要市场趋势

  • 溶瘤病毒免疫治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 溶瘤病毒免疫治疗市场限制
    • 市场限制影响分析
  • 溶瘤病毒免疫治疗市场机会
  • 溶瘤病毒免疫治疗市场未来趋势

第 4 章：溶瘤病毒免疫治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：溶瘤病毒免疫治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：溶瘤病毒免疫治疗市场格局

  • 2023 年溶瘤病毒免疫治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：溶瘤病毒免疫治疗市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 基于痘苗病毒的溶瘤病毒
    • 基于水泡性口炎病毒的溶瘤病毒
    • 基于 HSV 的溶瘤病毒
    • 基于腺病毒的溶瘤病毒
    • 基于新城疫病毒的溶瘤病毒

第 8 章：溶瘤病毒免疫治疗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 摄护腺癌
    • 膀胱癌
    • 黑色素瘤
    • 卵巢癌
    • 乳癌
    • 肺癌
    • 骨髓瘤
    • 其他的

第 9 章：溶瘤病毒免疫治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 专科诊所
    • 医院
    • 癌症研究机构

第 10 章：溶瘤病毒免疫治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美溶瘤病毒免疫疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲溶瘤病毒免疫疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区溶瘤病毒免疫疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲溶瘤病毒免疫疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲溶瘤病毒免疫疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-溶瘤病毒免疫治疗产业

  • 竞争仪表板
  • 公司简介
    • Amgen, Inc.
    • Sorrento Therapeutics Inc.
    • Merck & Co., Inc.
    • Oncolytics Biotech, Inc.
    • Viralytics Ltd.
    • Shanghai Sunway Biotech Co., Ltd.
    • SillaJen, Inc.
    • RIGVIR Ltd.
    • ORYX GmbH & Co. KG
    • Cold Genesys, Inc.
    • Transgene Biotek Ltd.

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2075

REPORT HIGHLIGHT

Oncolytic Virus Immunotherapy Market size was valued at USD 110 Million in 2023, expanding at a CAGR of 24.5% from 2024 to 2032.

The oncolytic viral immunotherapy includes the use of viruses to infect and then kill cells with cancer. It is well-recognized that cancer cells have weakened antiviral defenses, leaving them more vulnerable to infections than healthy body cells. Oncolytic viruses are designed to deliver therapeutic payloads to tumor cells while exhibiting a reduced capacity to infect healthy cells.

Oncolytic Virus Immunotherapy Market- Market Dynamics

Increasing collaboration to propel market demand

The increasing collaboration is expected to propel the market growth during the forecast period. For instance, in January 2022, Siga Technologies and Bioarchitech formed a preclinical partnership to study immunotherapy as a cancer treatment. The TPOXX (tecovirimat) and Bioarchitech's patented "vaccinia-based immunotherapy platform," which makes use of tailored antibodies and other proteins found in the oncolytic virus's genome, are the subjects of the research partnership. Moreover, in January 2024, the clinical evaluation of the customized neoantigen cancer vaccine TG4050 will continue due to the signing of a further development collaboration agreement by NEC Corporation, a leader in IT, network, and AI technologies, and Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer.

Oncolytic Virus Immunotherapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 24.5% over the forecast period (2024-2032)
  • Based on application segmentation, prostate cancer is expected to grow at a significant rate over the projected timeframe
  • Based on end-user segmentation, the hospitals segment is expected to dominate the market during the forecast period
  • Based on region, North America is expected to hold a prominent market share during the forecast period

Oncolytic Virus Immunotherapy Market- Segmentation Analysis:

  • The Global Oncolytic Virus Immunotherapy Market is segmented based on Product Type, Application, End-User, and Region.
  • Based on the product type, the market is bifurcated into Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, HSV-based Oncolytic Viruses, Adenovirus-based Oncolytic Viruses and Newcastle Disease Virus-based Oncolytic Viruses.
  • Based on the application, the global industry is segmented into Prostate Cancer, Bladder Cancer, Melanoma, Ovarian Cancer, Breast Cancer, Lung Cancer, Myeloma and Others. Prostate cancer is expected to grow at a significant rate over the projected timeframe. The growth in the segment is attributed to the increasing prevalence of prostate cancer. For instance, according to secondary analysis, except for skin cancer, prostate cancer is the most frequent cancer among males. An estimated 288,300 males in the US will receive a prostate cancer diagnosis in 2023. In 2020, a projected 1,414,259 individuals received a prostate cancer diagnosis worldwide. It ranks as the fourth most prevalent kind of cancer worldwide.
  • Based on the end-user, the market is divided into Specialty Clinics, Hospitals and Cancer Research Institutes. The hospital segment is expected to dominate the market during the forecast period. In a hospital setting, where qualified medical staff can keep an eye on patients both during and after treatment, oncolytic viral immunotherapy is usually given. Hospitals are also frequently participating in oncolytic virus immunotherapy clinical studies. In many cancer types, these studies evaluate the safety and effectiveness of certain treatments.

Oncolytic Virus Immunotherapy Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a prominent market share during the forecast period because the number of patients is growing in comparison to other nations. The market is expanding as a result of the United States' increased cancer incidence rates. According to the American Cancer Society's 2021 report, 608,570 people died from cancer in the US in 2021, while an anticipated 1.9 million new cases of cancer were identified. The other reasons that contribute to the growth of the market include increased knowledge about different cancer therapies, the availability of sophisticated immune-oncology medications in the area, and the expanding healthcare spending in countries such as the United States. The Centers for Medicare and Medicaid Services (CMS) released data showing that U.S. healthcare spending increased by 9.7% in 2020 to reach USD 4.1 trillion, or USD 12,530 per person. Health spending made up 19.7 percent of the country's GDP. Thus, driving the market expansion in the region.

Oncolytic Virus Immunotherapy Market- Competitive Landscape:

The key players operating in the market are: Amgen, Inc., Sorrento Therapeutics Inc., Merck & Co., Inc., Oncolytics Biotech, Inc., Viralytics Ltd., Shanghai Sunway Biotech Co., Ltd., SillaJen, Inc., RIGVIR Ltd., ORYX GmbH & Co. KG, Cold Genesys, Inc. and Transgene Biotek Ltd. These players adopted various strategies to remain competitive in the market which include, product launches, acquisitions, collaboration, agreements and others.

Recent Developments:

In July 2022, ABL, a pure play Contract Development and Manufacturing Organization (CDMO) focused on the creation and production of viruses for gene and cancer therapies, vaccine candidates, and other applications, announced its collaboration with KaliVir Immunotherapeutics, a privately held biotech business creating state-of-the-art, next-generation oncolytic viral immunotherapy programs. For the impending clinical study, ABL will produce the oncolytic viruses developed by KaliVir.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen, Inc.
  • Sorrento Therapeutics Inc.
  • Merck & Co., Inc.
  • Oncolytics Biotech, Inc.
  • Viralytics Ltd.
  • Shanghai Sunway Biotech Co., Ltd.
  • SillaJen, Inc.
  • RIGVIR Ltd.
  • ORYX GmbH & Co. KG
  • Cold Genesys, Inc.
  • Transgene Biotek Ltd.

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • HSV-based Oncolytic Viruses
  • Adenovirus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Prostate Cancer
  • Bladder Cancer
  • Melanoma
  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Myeloma
  • Others

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Hospitals
  • Cancer Research Institutes

GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Oncolytic Virus Immunotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Oncolytic Virus Immunotherapy Market Snippet by Product Type
    • 2.1.2. Oncolytic Virus Immunotherapy Market Snippet by Application
    • 2.1.3. Oncolytic Virus Immunotherapy Market Snippet by End-User
    • 2.1.4. Oncolytic Virus Immunotherapy Market Snippet by Country
    • 2.1.5. Oncolytic Virus Immunotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Oncolytic Virus Immunotherapy Key Market Trends

  • 3.1. Oncolytic Virus Immunotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Oncolytic Virus Immunotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Oncolytic Virus Immunotherapy Market Opportunities
  • 3.4. Oncolytic Virus Immunotherapy Market Future Trends

4. Oncolytic Virus Immunotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Oncolytic Virus Immunotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Oncolytic Virus Immunotherapy Market Landscape

  • 6.1. Oncolytic Virus Immunotherapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Oncolytic Virus Immunotherapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vaccinia Virus-based Oncolytic Viruses
    • 7.1.3. Vesicular Stomatitis Virus-based Oncolytic Viruses
    • 7.1.4. HSV-based Oncolytic Viruses
    • 7.1.5. Adenovirus-based Oncolytic Viruses
    • 7.1.6. Newcastle Disease Virus-based Oncolytic Viruses

8. Oncolytic Virus Immunotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Prostate Cancer
    • 8.1.3. Bladder Cancer
    • 8.1.4. Melanoma
    • 8.1.5. Ovarian Cancer
    • 8.1.6. Breast Cancer
    • 8.1.7. Lung Cancer
    • 8.1.8. Myeloma
    • 8.1.9. Others

9. Oncolytic Virus Immunotherapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Hospitals
    • 9.1.4. Cancer Research Institutes

10. Oncolytic Virus Immunotherapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Oncolytic Virus Immunotherapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Oncolytic Virus Immunotherapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Oncolytic Virus Immunotherapy Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Oncolytic Virus Immunotherapy Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Oncolytic Virus Immunotherapy Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Oncolytic Virus Immunotherapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Amgen, Inc.
    • 11.2.2. Sorrento Therapeutics Inc.
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. Oncolytics Biotech, Inc.
    • 11.2.5. Viralytics Ltd.
    • 11.2.6. Shanghai Sunway Biotech Co., Ltd.
    • 11.2.7. SillaJen, Inc.
    • 11.2.8. RIGVIR Ltd.
    • 11.2.9. ORYX GmbH & Co. KG
    • 11.2.10. Cold Genesys, Inc.
    • 11.2.11. Transgene Biotek Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Oncolytic Virus Immunotherapy Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Product Type 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Application 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Oncolytic Virus Immunotherapy Market, by End-User 2019-2032 (USD Million)
  • TABLE Oncolytic Virus Immunotherapy Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Oncolytic Virus Immunotherapy Market, by Region 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Oncolytic Virus Immunotherapy Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Oncolytic Virus Immunotherapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Germany Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE India Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Brazil Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Oncolytic Virus Immunotherapy Market share analysis by country, 2023
  • FIGURE Saudi Arabia Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Oncolytic Virus Immunotherapy Market size, forecast and trend analysis, 2019 to 2032 (USD Million)